.jpg?format=webp&width=780)
The association of comorbidities with perioperative outcomes after transoral robotic surgery (TORS) is not well‐defined in the literature. Using the National Cancer Database, 4004 patients with T1‐T2 oropharyngeal cancer between 2010 and 2017 were stratified based on their Charlson–Deyo Comorbidity Class (CDCC). LOS was greater for patients with CDCC 2 or 3 compared to CDCC 0 or 1 (p < 0.001). Increasing age and CDCC ≥3 were associated with 30‐day mortality (CDCC ≥3: odds ratio [OR] 5.55, 95% confidence interval [CI] 1.59–19.45). CDCC ≥3 (OR 2.61, 95%CI 1.09–6.27) was significantly associated with 30‐day readmissions. This national analysis demonstrates more excellent rates of unplanned 30‐day readmissions, longer hospitalizations, and increased 30‐ and 90‐day mortality after TORS in patients with CDCC ≥3.
Like
Save
Share